Vincent Cottin

Spectrum of Fibrotic Lung Diseases.

V. Cottin, M. Wijsenbeek, Vincent Cottin, 2020, The New England journal of medicine.

Idiopathic pulmonary fibrosis with benign SFTPC variant and pathogenic MARS1 mutations: can't see the forest for the trees!

R. Epaud, C. Delestrain, R. Diesler, 2023, ERJ Open Research.

High risk of lung cancer in surfactant-related gene variant carriers

G. Defossez, A. Guillaumot, M. Debray, 2024, The European respiratory journal.

Interstitial Lung Disease Associated with Systemic Sclerosis.

Valentine Mismetti, Vincent Cottin, S. Si-Mohamed, 2024, Seminars in respiratory and critical care medicine.

Rituximab as maintenance therapy for ANCA-associated vasculitides: pooled analysis and long-term outcome of 277 patients included in the MAINRITSAN trials

B. Bonnotte, E. Daugas, F. Maurier, 2023, Annals of the Rheumatic Diseases.

Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults

P. Brillet, J. Traclet, S. Papiris, 2024, Respirology.

Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort

J. Dalphin, S. Amselem, V. Cottin, 2021, Advances in Therapy.

Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial

T. Corte, Ganesh Raghu, Yoshikazu Inoue, 2024, American journal of respiratory and critical care medicine.

Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis.

M. Boubaya, R. Borie, C. Kannengiesser, 2023, Annals of the American Thoracic Society.